Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
Authors:
- M PulsipherMPM Pulsipher
- D ChenDCD Chen
- C SieffCSC Sieff
- A EliasAEA Elias
- H A FineHFH A Fine
- D W KufeDKD W Kufe
Open Access
- 1 December 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 98 (11) , 2539-2548
Abstract
Tumor contamination of bone marrow (BM) and peripheral blood (PB) may affect the outcome of patients receiving high dose chemotherapy with autologous transplantation of hematopoietic stem cell products. In this report, we demonstrate that replication defective adenoviral vectors containing the cytomegalovirus (CMV) or DF3/MUC1 carcinoma-selective promoter can be used to selectively transduce contaminating carcinoma cells. Adenoviral-mediated reporter gene expression in breast cancer cells was five orders of magnitude higher than that found in BM, PB, and CD34+ cells. Our results demonstrate that CD34+ cells have low to undetectable levels of integrins responsible for adenoviral internalization. We show that adenoviral-mediated transduction of a reporter gene can detect one breast cancer cell in 5 x 10(5) BM or PB cells with a vector containing the DF3/MUC1 promoter. We also show that transduction of the HSV-tk gene for selective killing by ganciclovir can be exploited for purging cancer cells from hematopoietic stem cell populations. The selective expression of TK followed by ganciclovir treatment resulted in the elimination of 6-logs of contaminating cancer cells. By contrast, there was little effect on CFU-GM and BFU-E formulation or on long term culture initiating cells. These results indicate that adenoviral vectors with a tumor-selective promoter provide a highly efficient and effective approach for the detection and purging of carcinoma cells in hematopoietic stem cell preparations.Keywords
This publication has 42 references indexed in Scilit:
- Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene.Proceedings of the National Academy of Sciences, 1993
- Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.Proceedings of the National Academy of Sciences, 1990
- EVALUATION OF MONOCLONAL-ANTIBODY DF3 CONJUGATED WITH RICIN AS A SPECIFIC IMMUNOTOXIN FOR INVITRO PURGING OF HUMAN BONE-MARROW1990
- ELIMINATION OF MALIGNANT CLONOGENIC BREAST-CANCER CELLS FROM HUMAN-BONE MARROW1989
- Receptor-mediated gene delivery and expression in vivo.Journal of Biological Chemistry, 1988
- Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ.Proceedings of the National Academy of Sciences, 1988
- REACTIVITY OF MONOCLONAL-ANTIBODY DF3 WITH A HIGH-MOLECULAR-WEIGHT ANTIGEN EXPRESSED IN HUMAN OVARIAN CARCINOMAS1986
- Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast TumorsHybridoma, 1984
- Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.The Journal of Immunology, 1981
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977